INTRODUCTIONInfluenza, one of the most commonplace seasonal maladies, and one of the most lethal, leaves behind it a long history of causing illness, death and financial loss (Nagata et al., ). Although the virus no longer carries the same gravitas as it once did, the World Health Organisation estimates that 5–15% of the world's population is infected with influenza every year and causes about 250,000–500,000 deaths (World Health Organisation, ). Complications and deaths caused by influenza continue particularly among vulnerable populations such as children, the immunosuppressed and the elderly (Longini & Halloran, ; World Health Organisation, ). Among the elderly, associated deaths continue to be high (Centers for Disease Control and Prevention (CDC), ; McBean, Babish, & Warren, ; Pop‐Vicas & Gravenstein, ; Simonsen, Taylor, Viboud, Miller, & Jackson, ). Vaccination is one of the most effective tools to prevent influenza and its related complications (Ehreth, ; Talbot et al., ; Udell et al., ). However, globally, vaccine coverage rates are low and World Health Organisation's target of at least 75% vaccination among the elderly is not being met by most countries (Palache, Oriol‐Mathieu, Fino, & Xydia‐Charmanta, ; World Health Organisation, ). Global influenza vaccination rates for those aged 65 + range from
Journal of Nursing Management – Wiley
Published: Jan 1, 2018
Keywords: ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera